Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
IRVING, Texas, March 11 /PRNewswire-FirstCall/ -- (RBC Life Sciences: OTC Bulletin Board: RBCL) -- RBC Life Sciences, Inc., a provider of proprietary nutritional supplements, wound care and pain...
BELOIT, Wis., Feb. 24 /PRNewswire-FirstCall/ -- Regal Beloit Corporation (NYSE:RBC) announced that management will not be attending the Gabelli 20th Annual Pump, Valve & Motor Symposium on...
- Annual Operating Cash Flow Exceeded $314 million - Energy Efficient Products Continue To Drive Sales Mix - Long-Term Benefits of Plant Rationalizations Continue To Be Realized - Short-Term...
BELOIT, Wis., Feb. 1 /PRNewswire-FirstCall/ -- Regal Beloit Corporation (NYSE:RBC) announced today that it plans to release its 2009 fourth quarter financial results after the market closes on...
- Energy Efficient Products Continue to Gain Traction - Plant Rationalizations Completed on Plan - Operating Cash Flow of $110.1 million BELOIT, Wis., Nov. 1 /PRNewswire-FirstCall/ -- Regal...
BELOIT, Wis., Oct. 29 /PRNewswire-FirstCall/ -- Regal Beloit Corporation (NYSE:RBC) will be presenting at the following conferences: Date Host Location November 3, Wedbush Clean...
BELOIT, Wis., Oct. 27 /PRNewswire-FirstCall/ -- Regal Beloit Corporation (NYSE:RBC) announced today that it plans to release its 2009 third quarter financial results before the market opens on...
BELOIT, Wis., Oct. 26 /PRNewswire-FirstCall/ -- Henry W. Knueppel, Chairman and Chief Executive Officer of REGAL BELOIT CORPORATION (NYSE:RBC), announced that the Board of Directors, at their...
- Operating Cash Flow of $106.8 million - Plant Rationalizations Proceeding on Plan - Legislation Continues to Support Energy Efficient Products BELOIT, Wis., Aug. 3 /PRNewswire-FirstCall/...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
